Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline HSLV Q1 2026 Earnings Silver Explorer Reports Stunning EPS Surprise Despite Absence of Revenue CCL Q1 2026 Earnings Cruise Operator Beats EPS Expectations Despite Market Pullback Palantir Q1 2026 Earnings EPS Beats Estimates by 1583 Stock Declines PFE Q1 2026 Earnings EPS Surprises to the Upside Amidst Operational Focus SBEV Q2 2025 Earnings Significant EPS Miss Reflects Ongoing Challenges